Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Anemia

Free Subscription Articles published in Hemoglobin Retrieve available abstracts of 106 articles: HTML format

Single Articles

March 2025
1. USSHER FA, Laing EF, Kontor EK, Atta-Owusu AB, et al
   Haplotype-Specific Genetic Epidemiology of Sickle Cell Anemia Patients in Accra, Ghana: Patterns, Clinical Implications, and Public Health Responses.
   Hemoglobin. 2025 Mar 5:1-9. doi: 10.1080/03630269.2025.2474609.
   PubMed     Abstract available
   
   
   January 2025
2. WINGER BA, Ajayi A, Vichinsky E
   Diagnosis and Treatment of Alpha Thalassemia Major.
   Hemoglobin. 2025;49:3-9.
   PubMed     Abstract available
   
   
   
3. HAMBLETON I, Mason K, Serjeant B, Serjeant G, et al
   Hypersplenism Affects Growth and Haematology in HbSS: Observations from the Jamaican Birth Cohort.
   Hemoglobin. 2025;49:47-53.
   PubMed     Abstract available
   
   
   
4. ALOOFY TA, Aleem A, Algahtani FH, Al-Shehri A, et al
   Long-Term Survival Rates of a Sickle Cell Disease Cohort in Saudi Arabia: A 2009-2023 Observational Study.
   Hemoglobin. 2025;49:54-59.
   PubMed     Abstract available
   
   
   
5. TEPAKHAN W, Attakan N, Kanjanaopas S, Srewaradachpisal K, et al
   Rapid Identification of beta-Thalassemia, Hb E, and High Hb F Determinants Using a High-Resolution Melting Analysis: Application in Prenatal Diagnosis in Southern Thailand.
   Hemoglobin. 2025;49:38-46.
   PubMed     Abstract available
   
   
   
6. TANG B, Chen K, Liang L, Li J, et al
   Characterization and Confirmation of Mildly Unstable Hb Pontoise or alpha1 63(E12) Ala > Asp and Literature Review.
   Hemoglobin. 2025;49:26-30.
   PubMed     Abstract available
   
   
   
7. SUALI L, Mohammad Salih FA, Ibrahim MY, Bin Jeffree MS, et al
   The Effect of Single Nucleotide Polymorphisms on Clinical Phenotypes of Sabahan Transfusion-Dependent beta-Thalassemia Patients with Homozygous Filipino beta(0)-Deletion.
   Hemoglobin. 2025;49:10-19.
   PubMed     Abstract available
   
   
   
8. ZENG GK, Yang YF, Ge YY, Yang Y, et al
   Identification of a beta-Globin Gene Mutation with the Genotype beta-28(A > G), IVS-I-5(G > A)/betaCD 71/72(+A) Using Third-Generation Sequencing.
   Hemoglobin. 2025;49:63-68.
   PubMed     Abstract available
   
   
   
9. HASSAN MK, Abbas RA, Hassan RA, Taghlubee IM, et al
   Prevalence and Spectrum of beta-Thalassemia Mutations in Baghdad, Iraq: Data from the Premarital Screening Program.
   Hemoglobin. 2025;49:31-37.
   PubMed     Abstract available
   
   
   
10. SEGUNMARU Z, Bayo F, Tobias AJ, Wingate LT, et al
    Knowledge of Sickle Cell Disease, Awareness of Sickle Cell Trait Status and Its Impact on Relationships Among Students at a Historically Black College.
    Hemoglobin. 2025;49:20-25.
    PubMed     Abstract available
    
    
    
11. ZHOU JY, Wang CY, Li J, Chen GL, et al
    First Reported Case of Hemoglobin H Disease Caused by the Rare alpha-Globin Gene Mutation (HBA2 c.244delT) in a Chinese Family.
    Hemoglobin. 2025;49:69-71.
    PubMed     Abstract available
    
    
    December 2024
12. MAKALO L, Adegoke SA, Allen SJ, Kuti BP, et al
    Sociodemographic and Clinical Factors Predictive of Poor Health-Related Quality of Life of Children with Sickle Cell Anemia in The Gambia.
    Hemoglobin. 2024 Dec 18:1-9. doi: 10.1080/03630269.2024.2440030.
    PubMed     Abstract available
    
    
    November 2024
13. DRYLLIS G, Russo R, Andolfo I, Iolascon A, et al
    Hereditary Hemolytic Anemia Due to PIEZO1 Red Blood Cell Membrane Defect.
    Hemoglobin. 2024 Nov 26:1-3. doi: 10.1080/03630269.2024.2427187.
    PubMed     Abstract available
    
    
    
14. NING S, Qin Y, Xie Y, Liang Y, et al
    The First Compound Heterozygosity for Two Different alpha-Thalassemia Determinants Causes Hb Bart's Hydrops Fetalis in a Chinese Family.
    Hemoglobin. 2024;48:384-388.
    PubMed     Abstract available
    
    
    
15. TAN L, Huang T, Luo L, Ma P, et al
    Molecular Identification and the Hematological Findings of Four Novel Variants in Globin Genes in Jiangxi Province of Southern China.
    Hemoglobin. 2024;48:369-374.
    PubMed     Abstract available
    
    
    
16. ASKARIAN-SARDARI F, Esmaeilian S, Hajimohammadi Z, Hayat-Nosaeid M, et al
    The Most Common Types of 3.7 Kilobase Deletion in the Iranian Population.
    Hemoglobin. 2024;48:365-368.
    PubMed     Abstract available
    
    
    September 2024
17. YE LH, Huang YY, Zhu ZT, Jiang AQ, et al
    alpha(0)-Thalassemia Caused by a Novel alpha-Globin Gene Cluster Deletion (-(LB)) Found in a Chinese Family.
    Hemoglobin. 2024;48:341-345.
    PubMed     Abstract available
    
    
    
18. KARNPEAN R, Tepakhan W, Rungruang K, Pongpatchara P, et al
    The Validation of Whole beta-Globin Gene Sequencing for Detecting beta-Thalassemia Mutations Found in Thailand Using Next-Generation Sequencing (NGS).
    Hemoglobin. 2024;48:333-340.
    PubMed     Abstract available
    
    
    
19. MAMMADOVA T, Asadov C, Alimirzoyeva Z, Abdulalimov E, et al
    Update on Prevention of Hemoglobinopathies in Azerbaijan.
    Hemoglobin. 2024;48:353-356.
    PubMed     Abstract available
    
    
    
20. LIANG JL, Ge YY, Xie LX, Zeng GK, et al
    Phenotypic Analysis of the HBA2: C.95 G > A Mutation in China.
    Hemoglobin. 2024;48:329-332.
    PubMed     Abstract available
    
    
    
21. ROMADHON PZ, Ashariati A, Bintoro SUY, Suryantoro SD, et al
    Existing Tubular Injury in beta-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia.
    Hemoglobin. 2024;48:301-307.
    PubMed     Abstract available
    
    
    
22. GUINDO A, Koya A, Sarro YDS, Toure AB, et al
    Analysis of Iron Status in Sickle Cell Disease Patients During Steady State at the Center de Recherche et de Lutte contre la Drepanocytose (CRLD) Bamako.
    Hemoglobin. 2024;48:314-318.
    PubMed     Abstract available
    
    
    
23. ABBAS RA, Hassan RH, Taghlubee IM, Mohammed SI, et al
    Prevalence and Molecular Characterization of beta-Thalassemia in Kirkuk Province of Northern Iraq.
    Hemoglobin. 2024;48:308-313.
    PubMed     Abstract available
    
    
    
24. GIUBBILEI C, D'Angelo S, Fotzi I, Mogni M, et al
    deltabeta-Thalassemia and alpha-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?
    Hemoglobin. 2024;48:349-352.
    PubMed     Abstract available
    
    
    July 2024
25. RASLAN IA, Solh Z, Kuo KHM, Abdulrehman J, et al
    Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Hemoglobin. 2024;48:231-243.
    PubMed     Abstract available
    
    
    
26. TAVASSOLI S, Chung JH, Panigrahi AR, Shahsavar A, et al
    Hemoglobin Balkh, a Novel Mutation in Codon 132 of alpha2-Globin Gene [alpha132(H15) (+T) or HBA2:C.396dup (p.Val134fs)]: A Case Report and Insight into the Pathophysiology.
    Hemoglobin. 2024;48:280-284.
    PubMed     Abstract available
    
    
    
27. YALCIN N, Sadri S, Ertinmaz Ozkan A, Gursoy V, et al
    Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia.
    Hemoglobin. 2024;48:292-300.
    PubMed     Abstract available
    
    
    
28. SERJEANT BE, Mason K, Reid M, Hambleton I, et al
    The Aplastic Crisis in HbSS: Observations from the Jamaican Birth Cohort.
    Hemoglobin. 2024;48:274-279.
    PubMed     Abstract available
    
    
    
29. POH KY, Bee PC
    First Report of Hb Youngstown in Capillary Electrophoresis and Overlapping Hb Analysis Findings with Hb Rush.
    Hemoglobin. 2024;48:254-257.
    PubMed     Abstract available
    
    
    
30. SONGDEJ D, Kadegasem P, Sirachainan N, Ruengdit C, et al
    The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for alpha-Thalassemia-1 Chiang Rai (--(CR)) Type Deletion with Hb Constant Spring.
    Hemoglobin. 2024;48:261-264.
    PubMed     Abstract available
    
    
    
31. COSKUN C, Unal S
    Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country.
    Hemoglobin. 2024;48:258-260.
    PubMed     Abstract available
    
    
    
32. KEITA M, Seck M, Diallo AB, Toure SA, et al
    Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.
    Hemoglobin. 2024;48:285-291.
    PubMed     Abstract available
    
    
    
33. JIANG F, Huang S, Liu T, Wang J, et al
    Identification of a Novel 16.8Kb Deletion of the alpha-Globin Gene Cluster by Third-Generation Sequencing.
    Hemoglobin. 2024;48:244-249.
    PubMed     Abstract available
    
    
    
34. DA SILVA ARAUJO A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, et al
    Sickle Cell Disease in Brazil: Current Management.
    Hemoglobin. 2024;48:218-230.
    PubMed     Abstract available
    
    
    June 2024
35. CHIGUER A, Lyahyai J, El Kadiri Y, Cherkaoui Jaouad I, et al
    Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia.
    Hemoglobin. 2024 Jun 4:1-4. doi: 10.1080/03630269.2024.2360456.
    PubMed     Abstract available
    
    
    May 2024
36. RAO E, Patel D, Saxena N, Saha KB, et al
    Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint.
    Hemoglobin. 2024;48:212-213.
    PubMed    
    
    
    
37. ASRI AS, Samsuddin MH, Jalil N, Mohamad Tahir N, et al
    Characterization of Hemoglobin Malay Phenotypes in Tertiary Hospitals.
    Hemoglobin. 2024;48:153-160.
    PubMed     Abstract available
    
    
    
38. SINGH R, Halder R, Hemant Gupta V, Rainchwar S, et al
    ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.
    Hemoglobin. 2024;48:186-191.
    PubMed     Abstract available
    
    
    
39. YAO C, Chen L, Ma J, Li N, et al
    A Novel Frameshift Mutation of HBB Causing Dominant beta-Thalassemia in a Chinese Individual.
    Hemoglobin. 2024;48:182-185.
    PubMed     Abstract available
    
    
    
40. BHATTACHARJEE S, Ghosh S, Shaw J, Bhattacharjee S, et al
    Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.
    Hemoglobin. 2024;48:161-168.
    PubMed     Abstract available
    
    
    
41. ADEGOKE SA, Makalo L, Sallah A, Saine H, et al
    Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Hemoglobin. 2024;48:169-174.
    PubMed     Abstract available
    
    
    
42. RAVICHANDRAN S, Hoffmann M, Petersen J, Sjo L, et al
    A Rare Case of De Novo Beta-Thalassemia Diagnosed by Whole-Genome Sequencing in an Ethnically Danish Newborn.
    Hemoglobin. 2024;48:196-199.
    PubMed     Abstract available
    
    
    
43. IBRAHIM L, Gwarzo DH, Yusuf AA
    Secretory Phospholipase A2 Levels Are High in Women with Sickle Cell Disease and Menstruation-Induced Vaso-Occlusive Crises.
    Hemoglobin. 2024;48:175-181.
    PubMed     Abstract available
    
    
    
44. HE X, Tian P, Zhong L, Peng S, et al
    A Novel 165 Kb Duplication Involving the alpha-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient.
    Hemoglobin. 2024;48:203-208.
    PubMed     Abstract available
    
    
    
45. PAN L, Wang Y, Lin H, Zhang X, et al
    A Novel Frameshift Mutation(HBA2:C.337delC) Associated With alpha-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2024;48:200-202.
    PubMed     Abstract available
    
    
    April 2024
46. KUMARI A, Chauhan G, Chaudhuri PK, Kumari S, et al
    Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis.
    Hemoglobin. 2024 Apr 18:1-12. doi: 10.1080/03630269.2024.2340685.
    PubMed     Abstract available
    
    
    March 2024
47. LIU D, Nong X, Lai F, Nong C, et al
    Noninvasive Prenatal Diagnosis of SEA-Thalassemia by Combining 1000 Genomes Database and Relative Haplotype Dosage.
    Hemoglobin. 2024;48:71-78.
    PubMed     Abstract available
    
    
    
48. VOUSVOUKI M, Delaki EE, Boutou E, Yfanti E, et al
    A New alpha1-Globin Variant, Hb Ormylia [HBA1:c.63C > G; p.His21Gln]. Report of Eleven Cases in Northern Greece.
    Hemoglobin. 2024;48:133-137.
    PubMed     Abstract available
    
    
    
49. ASSAF N, El Zibaoui R, Monsef C, Abi Nassif T, et al
    Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two alpha-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.
    Hemoglobin. 2024;48:129-132.
    PubMed     Abstract available
    
    
    
50. CHIN N, Asnani M
    Poor Sleep Quality in Jamaican Adults With Sickle Cell Disease: Prevalence, Risk Factors, and Association With Quality of Life.
    Hemoglobin. 2024;48:87-93.
    PubMed     Abstract available
    
    
    
51. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    Newborn Screening for beta-Thalassemia Identifies a Complex Genotype Involving a Novel beta-Globin Gene Mutation (HBB:c.336dup).
    Hemoglobin. 2024;48:113-115.
    PubMed     Abstract available
    
    
    
52. AL-ALLAWI N, Atroshi SD, Sadullah RK, Eissa AA, et al
    A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With beta-Thalassemia.
    Hemoglobin. 2024;48:94-100.
    PubMed     Abstract available
    
    
    
53. WAYE JS, Hanna M, Nakamura L, Walker L, et al
    Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/beta(0)-Thalassemia.
    Hemoglobin. 2024;48:116-117.
    PubMed     Abstract available
    
    
    February 2024
54. JIANG H, Li DZ
    Early Onset of Severe Anemia Caused by Hb Calgary (HBB: C.194G > T): Another Case Report.
    Hemoglobin. 2024 Feb 12:1-3. doi: 10.1080/03630269.2024.2315188.
    PubMed     Abstract available
    
    
    January 2024
55. KHOSHNAW NSH, Omar JJ, Hussein ZS, Mohammed RN, et al
    Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
    Hemoglobin. 2024;48:56-59.
    PubMed     Abstract available
    
    
    
56. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    beta(0)-Thalassemia Caused by a Novel Nonsense Mutation [HBB:c.199A > T].
    Hemoglobin. 2024;48:69-70.
    PubMed     Abstract available
    
    
    
57. CHUANSUMRIT A, Songdej D, Sirachainan N, Kadegasem P, et al
    Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload.
    Hemoglobin. 2024;48:47-55.
    PubMed     Abstract available
    
    
    
58. DESAI G, Dave K, Devare S, Desai S, et al
    Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease.
    Hemoglobin. 2024;48:66-68.
    PubMed    
    
    
    
59. WU SM, Li C, Huang SR, Jiang F, et al
    A 6-Year Follow-up of a Chinese Child with Homozygous beta(0)-Thalaasemia and a Heterozygous KLF1 Mutation.
    Hemoglobin. 2024;48:60-62.
    PubMed     Abstract available
    
    
    
60. DE OLIVEIRA TAQUES W, Bett GC, de Moraes BLB, Medeiros I, et al
    Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study.
    Hemoglobin. 2024;48:39-46.
    PubMed     Abstract available
    
    
    
61. MAMATA M, Padma G, Pragna Laxmi T, Saroja K, et al
    Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia.
    Hemoglobin. 2024;48:1-3.
    PubMed     Abstract available
    
    
    
62. LADU AI, Kadaura MU, Dauda M, Baba AS, et al
    Malaria Infection in Patients with Sickle Cell Disease in Nigeria: Association with Markers of Hyposplenism.
    Hemoglobin. 2024;48:15-23.
    PubMed     Abstract available
    
    
    
63. ZHENG LH, Liang L, Bai JP, Liao HX, et al
    Misdiagnosis of beta-Thalassemia Major Due to Chinese (G)gamma+((A)gammadeltabeta)(0)-Thalassemia Combined with beta(0)-Thalassemia.
    Hemoglobin. 2024;48:24-29.
    PubMed     Abstract available
    
    
    
64. CHEN M, Lv A, Zhang S, Zheng J, et al
    First Report of Filipino beta(0)-Thalassemia/beta-Thalassemia in a Chinese Family.
    Hemoglobin. 2024;48:34-38.
    PubMed     Abstract available
    
    
    November 2023
65. SILVA BORBOREMA T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R, et al
    Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Hemoglobin. 2023;47:85-96.
    PubMed     Abstract available
    
    
    
66. SAEIDNIA M, Fazeli P, Farzi A, Atefy Nezhad M, et al
    An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
    Hemoglobin. 2023;47:56-70.
    PubMed     Abstract available
    
    
    
67. QIU Y, Wei S, Hou W, Lai K, et al
    Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare beta-Globin Mutations.
    Hemoglobin. 2023;47:52-55.
    PubMed     Abstract available
    
    
    
68. ARAUJO ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, et al
    Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
    Hemoglobin. 2023;47:71-79.
    PubMed     Abstract available
    
    
    
69. TANG HS, Xiong Y, Li DZ
    Fetal Hemoglobin H Hydrops Fetalis: Another Three Case Reports.
    Hemoglobin. 2023;47:102-104.
    PubMed     Abstract available
    
    
    
70. LIU D, Nong C, Lai F, Tang Y, et al
    Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia.
    Hemoglobin. 2023;47:80-84.
    PubMed     Abstract available
    
    
    
71. WU BD, Zhou XY, Xie MJ, Jin CC, et al
    Identification of a Novel 7-bp Deletion in the alpha-Globin Gene Cluster in One Chinese Family.
    Hemoglobin. 2023;47:49-51.
    PubMed     Abstract available
    
    
    
72. LONG J, Gong F, Sun L, Yu C, et al
    A novel alpha Globin Gene Cluster Duplication, alphaalphaalphaalpha(380) Heterozygous beta(0)-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype.
    Hemoglobin. 2023;47:25-30.
    PubMed     Abstract available
    
    
    
73. DEMIDOVA E, Salomashkina V, Selivanova D, Litvin E, et al
    Hb Ryazan: An Elongated C-Terminal beta-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25.
    Hemoglobin. 2023;47:97-101.
    PubMed     Abstract available
    
    
    
74. EGHBALI A, Ghaffari K, Shaykh Baygloo R, Eghbali A, et al
    Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
    Hemoglobin. 2023;47:42-48.
    PubMed     Abstract available
    
    
    
75. SEYDEL GS, Ayan D, Balci T, Bayraktar M, et al
    Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.
    Hemoglobin. 2023;47:36-41.
    PubMed     Abstract available
    
    
    
76. ZHANG W, Han X, Deng J, Zhou R, et al
    Two Novel alpha-Thalassemia Mutations CD 39 -C [Thr > Pro] and CD 109 ACC > CCC [Thr > Pro] Identified in Two Chinese Families: A Case Report.
    Hemoglobin. 2023;47:172-179.
    PubMed     Abstract available
    
    
    
77. XIAO ZQ, Jiang F, Li DZ
    beta-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.
    Hemoglobin. 2023;47:145-146.
    PubMed     Abstract available
    
    
    
78. HAJIMOHAMMADI Z, Alimohammadi-Bidhendi S, Bagheri Amiri F, Karimipoor M, et al
    Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions.
    Hemoglobin. 2023;47:163-166.
    PubMed     Abstract available
    
    
    
79. KHATER D, Al-Mulaabed S, Alomairi A, Elshinawy M, et al
    Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose.
    Hemoglobin. 2023;47:157-162.
    PubMed     Abstract available
    
    
    
80. 'ULYA NM, Indrawati VN, Wulansari WT, Lesmana I, et al
    Mutation Spectrum of beta-Globin Gene in Patients with beta-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
    Hemoglobin. 2023;47:152-156.
    PubMed     Abstract available
    
    
    
81. YILDIRIM AT, Gulen H, Turkmen H, Ozek G, et al
    Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation.
    Hemoglobin. 2023;47:137-139.
    PubMed     Abstract available
    
    
    
82. BAZAZZADEGAN N, Abedini SS, Azarkeivan A, Banihashemi S, et al
    The Spectrum of HBB Mutations among 2315 Beta Thalassemia Patients of a Reference Clinic in Tehran-Iran.
    Hemoglobin. 2023;47:147-151.
    PubMed     Abstract available
    
    
    
83. BABU BV, Sharma Y, Sridevi P, Surti SB, et al
    Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Hemoglobin. 2023;47:227-236.
    PubMed     Abstract available
    
    
    
84. HAMALI HA
    Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hemoglobin. 2023;47:205-214.
    PubMed     Abstract available
    
    
    
85. MURAD H, Moassas F, Ali B, Katranji E, et al
    The Spectrum of alpha-Thalassemia Mutations in Syrian Patients.
    Hemoglobin. 2023;47:245-248.
    PubMed     Abstract available
    
    
    
86. KEOWMANI T, Teo SC, Yap KC, Chua WL, et al
    Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study.
    Hemoglobin. 2023;47:237-244.
    PubMed     Abstract available
    
    
    September 2023
87. GREWAL A, Kakkar S, Dewan P, Bansal N, et al
    Prevalence, Severity, and Determinants of Pain in Thalassemia.
    Hemoglobin. 2023;47:191-197.
    PubMed     Abstract available
    
    
    
88. RASHID NW, Al-Allawi N, Tahir HI
    Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease.
    Hemoglobin. 2023;47:198-201.
    PubMed     Abstract available
    
    
    
89. SINGH P, Shaikh S, Parmar S, Gupta R, et al
    Current Status of beta-Thalassemic Burden in India.
    Hemoglobin. 2023;47:181-190.
    PubMed     Abstract available
    
    
    July 2023
90. ABU-ISMAIL L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, et al
    COVID-19 and Anemia: What Do We Know So Far?
    Hemoglobin. 2023 Jul 31:1-8. doi: 10.1080/03630269.2023.2236546.
    PubMed     Abstract available
    
    
    May 2023
91. LIU L, Fu Q, Zhang D, Chen D, et al
    Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
    Hemoglobin. 2023 May 10:1-5. doi: 10.1080/03630269.2023.2206575.
    PubMed     Abstract available
    
    
    
92. AL-ZEBARI S, Al-Allawi NA, Nerweyi F
    Beta Globin Gene Cluster Haplotypes in Beta Thalassemia in the Kurdistan Region of Iraq.
    Hemoglobin. 2023;47:111-117.
    PubMed     Abstract available
    
    
    
93. SHAMOON R, Yassin A, Charkaneh A
    Detection of a Rare Mutation in the Initiation Codon of the beta-Globin Gene (HBB:C.2T > C; P.Met1Thr).
    Hemoglobin. 2023;47:118-121.
    PubMed     Abstract available
    
    
    
94. CHEN YP, Wu P, Wang H, Wu JF, et al
    A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C beta 68(E12) Leu-Pro]: A First Report in the Chinese Population.
    Hemoglobin. 2023;47:130-134.
    PubMed     Abstract available
    
    
    
95. KUMAR R, Ahmad SA, Ozdemir M, Sadayappan S, et al
    Mutation Spectrum of beta-Thalassemia in Some Ethnic Groups of North Maharashtra, India.
    Hemoglobin. 2023;47:105-110.
    PubMed     Abstract available
    
    
    January 2023
96. PUROHIT P, Mohanty PK, Panigrahi J, Das K, et al
    Effect of alpha(+) Thalassemia on the Severity of Plasmodium falciparum Malaria in Different Sickle Cell Genotypes in Indian Adults: A Hospital-Based Study.
    Hemoglobin. 2023;47:11-18.
    PubMed     Abstract available
    
    
    
97. KABIR T, Anwar S, Mourosi JT, Akter S, et al
    alpha- and beta-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh.
    Hemoglobin. 2023;47:3-10.
    PubMed     Abstract available
    
    
    
98. PAN L, Tian P, Chen S, Zhang R, et al
    Novel Promoter Mutation (HBB:C.-139_-138del) Associated with beta-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2023;47:21-24.
    PubMed     Abstract available
    
    
    November 2022
99. WEN YJ, Yu QX, Jiang F, Li DZ, et al
    Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
    Hemoglobin. 2022;46:347-350.
    PubMed     Abstract available
    
    
    
100. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
     Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
     Hemoglobin. 2022;46:297-302.
     PubMed     Abstract available
     
     
     
101. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
     Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
     Hemoglobin. 2022;46:308-311.
     PubMed     Abstract available
     
     
     
102. WU SM, Huang SR, Li C, Chen GL, et al
     Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
     Hemoglobin. 2022;46:341-343.
     PubMed     Abstract available
     
     
     
103. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
     Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
     Hemoglobin. 2022;46:317-324.
     PubMed     Abstract available
     
     
     
104. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
     Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
     Hemoglobin. 2022;46:303-307.
     PubMed     Abstract available
     
     
     
105. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
     A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
     Hemoglobin. 2022;46:338-340.
     PubMed     Abstract available
     
     
     
106. LONG J, Gong F, Sun L, Lai G, et al
     Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
     Hemoglobin. 2022;46:325-329.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.